Вісник проблем біології і медицини (Mar 2022)

CLINICAL CASE OF HEMORRHAGIC CYSTITIS TREATMENT COMPLICATED BY HEMOTAMPONADE OF THE BLADDER IN A PATIENT IN THE EXTRACORPOREAL PROGRAM FERTILIZATION

  • Nikiforov O. A.,
  • Letsin D. V.

DOI
https://doi.org/10.29254/2077-4214-2022-1-163-146-150
Journal volume & issue
no. 1
pp. 146 – 150

Abstract

Read online

Aim of the research. Description of a clinical case using the various methods of diagnosis and treatment of hemorrhagic cystitis in the extracorporeal program fertilization. Object and methods of research. A 29-year-old patient К. presented with hemorrhagic cystitis complicated by bladder hemotamponade, which was a result of in vitro fertilization. For the purpose of investigation and monitoring of the patient condition complete blood count, basic metabolic panel, urine test and ultrasonography of the abdomen and the cystoscopy were performed. Management was based on the current Ukrainian medical guidelines. Research results and discussion. After a thorough investigation of this clinical case, we can say that the patient had hemorrhagic cystitis complicated by hemotamponade of the bladder as a result of in vitro fertilization. Each individual patient should have an individual approach when choosing protocols for medical ovarian stimulation in an in vitro fertilization program. Conclusions. When using assisted reproductive technologies in patients in the in vitro fertilization program, complications may occur during and after transvaginal follicle puncture. Transvaginal puncture of the follicles carries the risk of bleeding, damage to the bladder, intestines or blood vessels. To date, a large number of clinical studies have been conducted in the in vitro fertilization program in order to ensure the safety of these procedures and with minimal risk to the patient. The variety of diseases manifested by hematuria, the features of the development and clinical course of these pathological processes require an integrated approach based on a multidisciplinary approach in the field of therapy, urology, gynecology, oncology and infectious pathology. The choice of protocol for medical ovarian stimulation should be based on individual approach, taking into account the degree of risk of any complication.

Keywords